Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Valeant's Hostile Bid For Cephalon

Apr 01 2011

Related Content

Endo Dives Deeper Into Devices With AMS Acquisition

Apr 01 2011

Tax Benefits Highlight Announced Merger Of Valeant And Biovail

Jun 21 2010

As Cephalon Rejects Valeant Bid, Valeant Officially Goes Hostile

Apr 06 2011

Valeant Makes Hostile $5.7B Bid for Cephalon

Mar 30 2011

Related Companies

Bausch Health Companies Inc.

Cephalon, Inc.

Teva Pharmaceutical Industries Ltd.

Gemin X Pharmaceuticals, Inc.

ChemGenex Pharmaceuticals Limited

Additional Topics

Deals Business Strategies BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window